<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">BJPsych Bull</journal-id><journal-id journal-id-type="iso-abbrev">BJPsych Bull</journal-id><journal-id journal-id-type="hwp">pbrcpsych</journal-id><journal-title-group><journal-title>BJPsych Bulletin</journal-title></journal-title-group><issn pub-type="ppub">2056-4694</issn><issn pub-type="epub">2056-4708</issn><publisher><publisher-name>Royal College of Psychiatrists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4706185</article-id><article-id pub-id-type="doi">10.1192/pb.bp.115.050930</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Papers</subject></subj-group></article-categories><title-group><article-title>The methamphetamine problem</article-title><subtitle>Commentary on &#x02026; Psychiatric morbidity and socio-occupational dysfunction in residents of a drug rehabilitation centre<sup><xref ref-type="fn" rid="fn1">&#x02020;</xref></sup></subtitle><fn-group><fn id="fn1"><label>&#x02020;</label><p>See original paper, pp. <related-article related-article-type="article-reference" id="d36e41" vol="39" page="213" issue="5" ext-link-type="pmc">213-217</related-article>, this issue.</p></fn></fn-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Galbraith</surname><given-names>Niall</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="A1"><label>1</label>University of Wolverhampton, UK</aff><author-notes><corresp id="cor1">
Correspondence to Niall Galbraith (<email>n.galbraith@wlv.ac.uk</email>)
</corresp><fn><p><bold>Niall Galbraith</bold> is Senior Lecturer in Psychology, University of Wolverhampton, West Midlands, UK.</p></fn></author-notes><pub-date pub-type="ppub"><month>10</month><year>2015</year></pub-date><volume>39</volume><issue>5</issue><fpage>218</fpage><lpage>220</lpage><history><date date-type="received"><day>18</day><month>2</month><year>2015</year></date><date date-type="accepted"><day>16</day><month>4</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 The Author</copyright-statement><copyright-year>2015</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an open-access article published by the Royal College of Psychiatrists and distributed under the terms of the Creative Commons Attribution License (<uri xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</uri>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="218.pdf"/><abstract><p id="P1">This paper introduces the reader to the characteristics of methamphetamine. Explored within are the drug's effects on those who consume it as well as the history and prevalence of its use. The highly addictive nature of methamphetamine is compounded by its affordability and the ease with which it is produced, with North America and East Asia having become established as heartlands for both consumption and manufacture. The paper discusses recent cultural depictions of the drug and also the role that mental health professionals may take in designing and delivering interventions to treat methamphetamine addiction.</p></abstract></article-meta></front><body><sec id="S1"><title>The nature of methamphetamine</title><p id="P2">Methamphetamine (&#x02018;meth&#x02019;) is a stimulant which increases levels of monoamines (particularly dopamine, but also noradrenaline and serotonin) in the central nervous system. Its pharmacological effects occur via a number of neurochemical processes, including disruption of vesicular<sup><xref rid="R1" ref-type="bibr">1</xref></sup> and transporter<sup><xref rid="R2" ref-type="bibr">2</xref></sup> functioning, through the inhibition of monoamine oxidase<sup><xref rid="R3" ref-type="bibr">3</xref></sup> and the facilitation of tyrosine hydroxylase.<sup><xref rid="R4" ref-type="bibr">4</xref></sup> Like other stimulants, such as cocaine and amphetamine, it produces feelings of euphoria, alertness and increased energy. Unlike cocaine though, a single dose of methamphetamine sustains these effects for many hours. Methamphetamine can be smoked, snorted, injected or swallowed. The psychological effects of long-term use include hallucinations and delusions, depression, suicidality and aggression.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Withdrawal may exacerbate these symptoms, while also leading to fatigue and intense craving.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> Long-term health effects are considerable, and include neural damage and associated cognitive impairment,<sup><xref rid="R7" ref-type="bibr">7</xref></sup> cardiovascular damage,<sup><xref rid="R8" ref-type="bibr">8</xref></sup> dental disease<sup><xref rid="R9" ref-type="bibr">9</xref></sup> and stroke.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> The drug is also associated with risky sexual behaviour, resulting in a high prevalence of sexually transmitted disease.<sup><xref rid="R11" ref-type="bibr">11</xref></sup> Methamphetamine is also noted for its addictiveness. Evidence shows that addiction occurs more rapidly than with cocaine<sup><xref rid="R12" ref-type="bibr">12</xref></sup> and that unlike with amphetamine, methamphetamine-seeking behaviour may persist even when tolerance is reached.<sup><xref rid="R13" ref-type="bibr">13</xref></sup> The trajectory of methamphetamine use over a 10-year period has been found to resemble that of heroin more so than that of cocaine.<sup><xref rid="R14" ref-type="bibr">14</xref></sup> Methamphetamine is also associated with criminality<sup><xref rid="R15" ref-type="bibr">15</xref></sup> and social decline.<sup><xref rid="R16" ref-type="bibr">16</xref></sup> It therefore represents a major public health, social and political dilemma.</p></sec><sec id="S2"><title>Who uses methamphetamine and where?</title><p id="P3">Across the world, methamphetamine use as a recreational drug has increased significantly since the 1990s, and it is reported as the second most widely misused substance, exceeded only by cannabis.<sup><xref rid="R17" ref-type="bibr">17</xref></sup> In the USA during the 1960s and 1970s, methamphetamine was produced and trafficked mainly by motorcycle gangs, mostly in California.<sup><xref rid="R18" ref-type="bibr">18</xref></sup> Patrons were typically White, male, blue-collar workers, but the drug has since become popular among white-collar workers, students, ethnic minorities and women,<sup><xref rid="R19" ref-type="bibr">19</xref></sup> and manufacturing has spread to Midwestern states.<sup><xref rid="R20" ref-type="bibr">20</xref></sup> One of the principal factors in its rise is the ease with which it can be manufactured. The chemicals necessary for its production (e.g. methylamine, ephedrine or pseudoephedrine) are relatively easy to obtain, as is the equipment required for the &#x02018;cooking&#x02019; process. This has led to a cottage industry in methamphetamine production, with home-based laboratories being commonly uncovered by law enforcement agencies in the USA<sup><xref rid="R21" ref-type="bibr">21</xref></sup> and in other parts of the world, particularly in Asia.<sup><xref rid="R22" ref-type="bibr">22</xref></sup> In addition to the home lab phenomenon, there exist industrial producers of methamphetamine, who manufacture and transport large quantities of the drug.<sup><xref rid="R23" ref-type="bibr">23</xref></sup> In North America, large-scale production occurs in both Mexico and Canada and the product is then brought across the border for sale within the USA. In the USA itself, 4.7% of respondents to a national survey admit to lifetime use of methamphetamine.<sup><xref rid="R24" ref-type="bibr">24</xref></sup></p><p id="P4">Data from Asia also indicate high levels of use. Japan has a long history of misuse, dating back to the 1940s,<sup><xref rid="R23" ref-type="bibr">23</xref></sup> when military stocks of methamphetamine flooded the market, giving rise to high incidence of misuse among young people. A second epidemic occurred in the 1970s, when use soared among blue-collar workers. This crisis has now stabilised and Japan's methamphetamine users now represent an aging population. Since the 1990s, the popularity of methamphetamine has spread to other East Asian countries. By 2007, 63% of worldwide methamphetamine seizures occurred within the Southeast Asian region, and it is estimated that half of the world's methamphetamine users are found there.<sup><xref rid="R25" ref-type="bibr">25</xref></sup> The Mekong region of Myanmar, close to the border of Thailand and China, is identified as Asia's most prolific production centre for methamphetamine. From there the drug is transported across the borders for sale in neighbouring countries.<sup><xref rid="R25" ref-type="bibr">25</xref></sup> In Myanmar, it is usually pressed into pill form, known colloquially as yaba (&#x02018;crazy medicine&#x02019;). Thailand has suffered its own epidemic, with methamphetamine treatment admissions rising dramatically in the late 1990s,<sup><xref rid="R26" ref-type="bibr">26</xref></sup> but evidence of increasing methamphetamine use is also found in Brunei, Laos, the Philippines<sup><xref rid="R22" ref-type="bibr">22</xref></sup> and Cambodia.<sup><xref rid="R27" ref-type="bibr">27</xref></sup></p><p id="P5">In Europe, the meth epidemic has not yet arrived, perhaps because there is already a congested market for stimulant drugs, although the Czech Republic and to a lesser extent Slovakia have a history of high methamphetamine use.<sup><xref rid="R28" ref-type="bibr">28</xref></sup> In Australia, use has increased in recent years but not dramatically.<sup><xref rid="R29" ref-type="bibr">29</xref></sup> In South Africa, the past decade has seen a significant increase in treatment admissions for methamphetamine.<sup><xref rid="R30" ref-type="bibr">30</xref></sup> This increase in methamphetamine use is positively associated with risk-taking sexual behaviour,<sup><xref rid="R31" ref-type="bibr">31</xref></sup> which if unchecked may in turn exacerbate an already urgent HIV epidemic.</p></sec><sec id="S3"><title>Cultural depictions of methamphetamine</title><p id="P6">The emergence of methamphetamine as one of the most widely used recreational drugs is associated with its rise in the media. Methamphetamine has become a cultural phenomenon, in much the same way that heroin, MDMA (contracted from 3,4-methylenedioxy-methamphetamine; ecstasy) and cannabis had become popularised already. The most obvious cultural reference to methamphetamine is in the hugely successful American drama series <italic>Breaking Bad</italic>. This drama describes the exploits of a terminally ill chemistry teacher who chooses to become a manufacturer and then seller of methamphetamine, initially to guarantee financial security for his family after his death. The series focuses on the corruption of the main character and the erosion of his relationships with those close to him. What is notable about the series though is that the problem of devastating effects of methamphetamine on individuals and communities occupies only a minor part in the story. The series has done much to publicise the existence of methamphetamine to households across the world, but in not fully exploring its sinister effects (other than the moral degeneration of those who manufacture it), the series runs the risk of sanitising or normalising this destructive drug to the wider society.</p><p id="P7">At the other extreme, also in the USA, there has been a widely publicised campaign to highlight the unpleasant physical effects of methamphetamine addiction. The &#x02018;Faces of Meth&#x02019; project<sup><xref rid="R32" ref-type="bibr">32</xref></sup> exposes police custody photographs of users, showing images of the same individual at different points in time, so as to longitudinally chronicle the ravages of the drug on physical appearance. These before and after photos &#x02013; which reveal apparently common features of long-term methamphetamine use: skin damage (caused by obsessive picking) and dental ill health (or &#x02018;meth mouth&#x02019; as it is colloquially known)<sup><xref rid="R33" ref-type="bibr">33</xref></sup> &#x02013; are designed to shock and appal observers. The effectiveness of the scheme is difficult to assess due to the absence of trials, however, the use of fear and shock is not always an effective deterrent in health campaigns and is generally regarded as inferior to positive reinforcement approaches.<sup><xref rid="R34" ref-type="bibr">34</xref></sup></p><p id="P8">The Faces of Meth-type approach has come under criticism from Naomi Murakawa,<sup><xref rid="R35" ref-type="bibr">35</xref></sup> who argues that its focus on the visual effects of methamphetamine, mostly in White methamphetamine users, represents a type of social panic. Murakawa argues that historically, drug panics in the USA have been constructed in line with racial prejudices (e.g. Chinese-focused opium scares, Mexican-focused cannabis scares and Black-focused crack scares). Methamphetamine addiction is often described along racial lines as a &#x02018;White trash&#x02019; phenomenon. Murakawa claims that decayed or missing teeth mark prevailing fears over the decline in White social status, as traditional representations of American so-called &#x02018;White trash&#x02019; typically depict poor dental health as a visual indicator of lower class.</p><p id="P9">Given the prevalence of methamphetamine use across the globe, considerable effort has been put into designing effective treatment programmes for its users. Broadly speaking, these interventions are pharmacological, psychosocial or community-based prevention approaches. The evidence in favour of pharmacological treatments is mixed, although some promising findings with modafinil, bupropion and naltrexone have been reported.<sup><xref rid="R36" ref-type="bibr">36</xref></sup> Psychosocial interventions have proved effective in the short term, but more evidence is needed to demonstrate long-term benefits.<sup><xref rid="R37" ref-type="bibr">37</xref></sup> Community-based prevention schemes have also shown evidence of benefit.<sup><xref rid="R38" ref-type="bibr">38</xref></sup> The promise shown by such interventions is encouraging, given the addictiveness of methamphetamine, the intensity and duration of cravings experienced by those who go through withdrawal<sup><xref rid="R6" ref-type="bibr">6</xref></sup> and also the psychological comorbidity. Interestingly for mental health professionals, there is evidence that the cost-effectiveness of treatment<sup><xref rid="R39" ref-type="bibr">39</xref></sup> and prevention<sup><xref rid="R38" ref-type="bibr">38</xref></sup> approaches may compare favourably with alternatives, such as, for example, interventions by law enforcement to disrupt the supply of the precursor chemicals needed for methamphetamine production.<sup><xref rid="R40" ref-type="bibr">40</xref></sup> Furthermore, given the advance of this drug across Asia and North America and its potential for expansion across thus far untapped markets (e.g. Europe and Africa), the further development of robust treatment programmes for the future is urgently needed.</p></sec></body><back><fn-group><fn fn-type="conflict"><p><bold>Declaration of interest</bold> None.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>JM</given-names></name><name><surname>Hanson</surname><given-names>GR</given-names></name><name><surname>Fleckenstein</surname><given-names>AE</given-names></name></person-group>
<article-title>Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants</article-title>. <source>J Pharmacol Exp Ther</source>
<year>2001</year>; <volume>296</volume>: <fpage>762</fpage>-<lpage>7</lpage>.
<pub-id pub-id-type="pmid">11181904</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fleckenstein</surname><given-names>AE</given-names></name><name><surname>Metzger</surname><given-names>RR</given-names></name><name><surname>Gibb</surname><given-names>JW</given-names></name><name><surname>Hanson</surname><given-names>GR</given-names></name></person-group>
<article-title>A rapid and reversible change in dopamine transporters induced by methamphetamine</article-title>. <source>Eur J Pharmacology</source>
<year>1997</year>; <volume>323</volume>: <fpage>R9</fpage>-<lpage>10</lpage>.
</mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mantle</surname><given-names>TJ</given-names></name><name><surname>Tipton</surname><given-names>KF</given-names></name><name><surname>Garrett</surname><given-names>NJ</given-names></name></person-group>
<article-title>Inhibition of monoamine oxidase by amphetamine and related compounds</article-title>. <source>Biochem Pharmacol</source>
<year>1976</year>; <volume>25</volume>: <fpage>2073</fpage>-<lpage>7</lpage>.
<pub-id pub-id-type="pmid">985546</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sulzer</surname><given-names>D</given-names></name><name><surname>Sonders</surname><given-names>MS</given-names></name><name><surname>Poulsen</surname><given-names>NW</given-names></name><name><surname>Galli</surname><given-names>A</given-names></name></person-group>
<article-title>Mechanisms of neurotransmitter release by amphetamines: a review</article-title>. <source>Prog Neurobiol</source>
<year>2005</year>; <volume>75</volume>: <fpage>406</fpage>-<lpage>33</lpage>.
<pub-id pub-id-type="pmid">15955613</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Darke</surname><given-names>S</given-names></name><name><surname>Kaye</surname><given-names>S</given-names></name><name><surname>McKetin</surname><given-names>R</given-names></name><name><surname>Duflou</surname><given-names>J</given-names></name></person-group>
<article-title>Major physical and psychological harms of methamphetamine use</article-title>. <source>Drug Alcohol Rev</source>
<year>2008</year>; <volume>27</volume>: <fpage>253</fpage>.
<pub-id pub-id-type="pmid">18368606</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McGregor</surname><given-names>C</given-names></name><name><surname>Srisurapanont</surname><given-names>M</given-names></name><name><surname>Jittiwutikarn</surname><given-names>J</given-names></name><name><surname>Laobhripatr</surname><given-names>S</given-names></name><name><surname>Wongtan</surname><given-names>T</given-names></name><name><surname>White</surname><given-names>JM</given-names></name></person-group>
<article-title>The nature, time course and severity of methamphetamine withdrawal</article-title>. <source>Addiction</source>
<year>2005</year>; <volume>100</volume>: <fpage>1320</fpage>-<lpage>9</lpage>.
<pub-id pub-id-type="pmid">16128721</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barr</surname><given-names>AM</given-names></name><name><surname>Panenka</surname><given-names>WJ</given-names></name><name><surname>MacEwan</surname><given-names>GW</given-names></name><name><surname>Thornton</surname><given-names>AE</given-names></name><name><surname>Lang</surname><given-names>DJ</given-names></name><name><surname>Honer</surname><given-names>WG</given-names></name><etal/></person-group>
<article-title>The need for speed: an update on methamphetamine addiction</article-title>. <source>J Psychiatr Neuroscience</source>
<year>2006</year>; <volume>31</volume>: <fpage>301</fpage>.
</mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaye</surname><given-names>S</given-names></name><name><surname>McKetin</surname><given-names>R</given-names></name><name><surname>Duflou</surname><given-names>J</given-names></name><name><surname>Darke</surname><given-names>S</given-names></name></person-group>
<article-title>Methamphetamine and cardiovascular pathology: a review of the evidence</article-title>. <source>Addiction</source>
<year>2007</year>; <volume>102</volume>: <fpage>1204</fpage>-<lpage>11</lpage>.
<pub-id pub-id-type="pmid">17565561</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shetty</surname><given-names>V</given-names></name><name><surname>Mooney</surname><given-names>LJ</given-names></name><name><surname>Zigler</surname><given-names>CM</given-names></name><name><surname>Belin</surname><given-names>TR</given-names></name><name><surname>Murphy</surname><given-names>D</given-names></name><name><surname>Rawson</surname><given-names>R</given-names></name></person-group>
<article-title>The relationship between methamphetamine use and increased dental disease</article-title>. <source>J Am Dent Assoc</source>
<year>2010</year>; <volume>141</volume>: <fpage>307</fpage>-<lpage>18</lpage>.
<pub-id pub-id-type="pmid">20194387</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rothrock</surname><given-names>JF</given-names></name><name><surname>Rubenstein</surname><given-names>R</given-names></name><name><surname>Lyden</surname><given-names>PD</given-names></name></person-group>
<article-title>Ischemic stroke associated with methamphetamine inhalation</article-title>. <source>Neurology</source>
<year>1988</year>; <volume>38</volume>: <fpage>589</fpage>-<lpage>92</lpage>.
<pub-id pub-id-type="pmid">3352918</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Halkitis</surname><given-names>PN</given-names></name><name><surname>Parsons</surname><given-names>JT</given-names></name><name><surname>Stirratt</surname><given-names>MJ</given-names></name></person-group>
<article-title>A double epidemic: crystal methamphetamine drug use in relation to HIV transmission</article-title>. <source>J Homosex</source>
<year>2001</year>; <volume>41</volume>: <fpage>17</fpage>-<lpage>35</lpage>.
<pub-id pub-id-type="pmid">11482426</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Castro</surname><given-names>FG</given-names></name><name><surname>Barrington</surname><given-names>EH</given-names></name><name><surname>Walton</surname><given-names>MA</given-names></name><name><surname>Rawson</surname><given-names>RA</given-names></name></person-group>
<article-title>Cocaine and methamphetamine: differential addiction rates</article-title>. <source>Psychology Addict Behav</source>
<year>2000</year>; <volume>14</volume>: <fpage>390</fpage>.
</mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shoblock</surname><given-names>JR</given-names></name><name><surname>Maisonneuve</surname><given-names>IM</given-names></name><name><surname>Glick</surname><given-names>SD</given-names></name></person-group>
<article-title>Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction</article-title>. <source>Psychopharmacol</source>
<year>2003</year>; <volume>170</volume>: <fpage>150</fpage>-<lpage>6</lpage>.
</mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hser</surname><given-names>YI</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Brecht</surname><given-names>ML</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Evans</surname><given-names>E</given-names></name></person-group>
<article-title>Contrasting trajectories of heroin, cocaine, and methamphetamine use</article-title>. <source>J Addict Dis</source>
<year>2008</year>; <volume>27</volume>: <fpage>13</fpage>-<lpage>21</lpage>.
<pub-id pub-id-type="pmid">18956525</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cartier</surname><given-names>J</given-names></name><name><surname>Farabee</surname><given-names>D</given-names></name><name><surname>Prendergast</surname><given-names>ML</given-names></name></person-group>
<article-title>Methamphetamine use, self-reported violent crime, and recidivism among offenders in California who abuse substances</article-title>. <source>J Interpers Violence</source>
<year>2006</year>; <volume>21</volume>: <fpage>435</fpage>-<lpage>45</lpage>.
<pub-id pub-id-type="pmid">16501213</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sommers</surname><given-names>I</given-names></name><name><surname>Baskin</surname><given-names>D</given-names></name><name><surname>Baskin-Sommers</surname><given-names>A</given-names></name></person-group>
<article-title>Methamphetamine use among young adults: health and social consequences</article-title>. <source>Addict Behav</source>
<year>2006</year>; <volume>31</volume>: <fpage>1469</fpage>-<lpage>76</lpage>.
<pub-id pub-id-type="pmid">16309848</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>World Health Organization</collab></person-group>
<source>Amphetamine-like Stimulants: A Report from the WHO Meeting on Amphetamines, MDMA and Other Psychostimulants, Geneva, 12-15 November 1996</source>. <publisher-name>WHO</publisher-name>, <year>1997</year>.
</mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Miller</surname><given-names>MA</given-names></name></person-group>
<article-title>History and epidemiology of amphetamine abuse in the United States</article-title>. In <source>Amphetamine Misuse: International Perspectives on Current Trends</source> (ed. <person-group person-group-type="editor"><name><surname>Klee</surname><given-names>H</given-names></name></person-group>): <fpage>113</fpage>&#x02013;<lpage>34</lpage>. <publisher-name>Harwood Academic Publishers</publisher-name>, <year>1997</year>.
</mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Potter</surname><given-names>MJ</given-names></name><name><surname>Kolbye</surname><given-names>KE</given-names></name></person-group>
<source>Effects of D-Methamphetamine</source>. <publisher-name>National Drug Intelligence Center</publisher-name>, <year>1996</year>.
</mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>Office of National Drug Control Policy</collab></person-group>
<source>Pulse Check: National Trends in Drug Abuse</source>. <publisher-name>ONDCP</publisher-name>, <year>1997</year>.
</mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>Centers for Disease Control and Prevention</collab></person-group>
<article-title>Public health consequences among first responders to emergency events associated with illicit methamphetamine laboratories &#x02013; selected states, 1996-1999</article-title>. <source>MMWR</source>
<year>2000</year>; <volume>49</volume>: <fpage>1021</fpage>-<lpage>4</lpage>.
<pub-id pub-id-type="pmid">11098778</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Kozel</surname><given-names>N</given-names></name><name><surname>Lund</surname><given-names>J</given-names></name><name><surname>Douglas</surname><given-names>J</given-names></name><name><surname>McKetin</surname><given-names>R</given-names></name></person-group>
<source>Patterns and Trends in Amphetamine-Type Stimulants in East Asia and the Pacific 2006</source>. <publisher-name>United Nations Office on Drugs and Crime Regional Centre for East Asia and the Pacific</publisher-name>, <year>2007</year>.
</mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Anglin</surname><given-names>MD</given-names></name><name><surname>Burke</surname><given-names>C</given-names></name><name><surname>Perrochet</surname><given-names>B</given-names></name><name><surname>Stamper</surname><given-names>E</given-names></name><name><surname>Dawud-Noursi</surname><given-names>S</given-names></name></person-group>
<article-title>History of the methamphetamine problem</article-title>. <source>J Psychoact Drugs</source>
<year>2000</year>; <volume>32</volume>: <fpage>137</fpage>-<lpage>41</lpage>.
</mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>Substance Abuse and Mental Health Services Administration</collab></person-group>
<source>Results from the 2007 National Survey on Drug Use and Health: National Findings</source>. <publisher-name>Office of Applied Statistics, NSDUH Series H-34, DHHS Publication No. SMA 08-4343. SAMHSA</publisher-name>, <year>2013</year>.
</mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>United Nations Office on Drugs and Crime</collab></person-group>
<source>2007 World Drug Report. Volume 1: Analysis</source>. <publisher-name>United Nations Office on Drugs and Crime</publisher-name>, <year>2007</year>.
</mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Devaney</surname><given-names>M</given-names></name><name><surname>Reid</surname><given-names>G</given-names></name><name><surname>Baldwin</surname><given-names>S</given-names></name></person-group>
<source>Situational Analysis of Illicit Drug Issues and Responses in the Asia-Pacific Region</source>. <publisher-name>Australian National Council on Drugs</publisher-name>, <year>2006</year>.
</mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>United Nations Office on Drugs and Crime</collab></person-group>
<source>Drug Abuse among Youth in Vientiane, School Survey</source>. <publisher-name>United Nations Office on Drugs and Crime Regional Centre for East Asia and the Pacific</publisher-name>, <year>2002</year>.
</mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>P</given-names></name><name><surname>Mravcik</surname><given-names>V</given-names></name><name><surname>Lopez</surname><given-names>D</given-names></name><name><surname>Klempova</surname><given-names>D</given-names></name></person-group>
<article-title>Quite a lot of smoke but very limited fire &#x02013; the use of methamphetamine in Europe</article-title>. <source>Drug Alcohol Rev</source>
<year>2008</year>; <volume>27</volume>: <fpage>236</fpage>-<lpage>42</lpage>.
<pub-id pub-id-type="pmid">18368604</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Degenhardt</surname><given-names>L</given-names></name><name><surname>Roxburgh</surname><given-names>A</given-names></name><name><surname>Black</surname><given-names>E</given-names></name><name><surname>Bruno</surname><given-names>RB</given-names></name><name><surname>Campbell</surname><given-names>G</given-names></name><name><surname>Kinner</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>The epidemiology of methamphetamine risk and harm in Australia</article-title>. <source>Drug Alcohol Rev</source>
<year>2008</year>; <volume>27</volume>: <fpage>243</fpage>-<lpage>52</lpage>.
<pub-id pub-id-type="pmid">18368605</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pl&#x000fc;ddemann</surname><given-names>A</given-names></name><name><surname>Myers</surname><given-names>BJ</given-names></name><name><surname>Parry</surname><given-names>CD</given-names></name></person-group>
<article-title>Surge in treatment admissions related to methamphetamine use in Cape Town, South Africa: implications for public health</article-title>. <source>Drug Alcohol Rev</source>
<year>2008</year>; <volume>27</volume>: <fpage>185</fpage>-<lpage>9</lpage>.
<pub-id pub-id-type="pmid">18264880</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pluddemann</surname><given-names>A</given-names></name><name><surname>Flisher</surname><given-names>AJ</given-names></name><name><surname>Mathews</surname><given-names>C</given-names></name><name><surname>Carney</surname><given-names>T</given-names></name><name><surname>Lombard</surname><given-names>C</given-names></name></person-group>
<article-title>Adolescent methamphetamine use and sexual risk behaviour in secondary school students in Cape Town, South Africa</article-title>. <source>Drug Alcohol Rev</source>
<year>2008</year>; <volume>7</volume>: <fpage>687</fpage>-<lpage>92</lpage>.
<pub-id pub-id-type="pmid">18825548</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Linnemann</surname><given-names>T</given-names></name><name><surname>Wall</surname><given-names>T</given-names></name></person-group>
<article-title>&#x02018;This is your face on meth&#x02019;: the punitive spectacle of &#x02018;white trash&#x02019; in the rural war on drugs</article-title>. <source>Theor Criminol</source>
<year>2013</year>; <volume>17</volume>: <fpage>315</fpage>-<lpage>34</lpage>.
</mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hendrickson</surname><given-names>RG</given-names></name><name><surname>Cloutier</surname><given-names>R</given-names></name><name><surname>John McConnell</surname><given-names>K</given-names></name></person-group>
<article-title>Methamphetamine-related emergency department utilization and cost</article-title>. <source>Acad Emerg Med</source>
<year>2008</year>; <volume>15</volume>: <fpage>23</fpage>-<lpage>31</lpage>.
<pub-id pub-id-type="pmid">18211309</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Soames Job</surname><given-names>RF</given-names></name></person-group>
<article-title>Effective and ineffective use of fear in health promotion campaigns</article-title>. <source>Am J Publ Health</source>
<year>1988</year>; <volume>78</volume>: <fpage>163</fpage>-<lpage>7</lpage>.
</mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murakawa</surname><given-names>N</given-names></name></person-group>
<article-title>Toothless</article-title>. <source>Du Bois Review: Soc Sci Res Race</source>
<year>2011</year>; <volume>8</volume>: <fpage>219</fpage>-<lpage>28</lpage>.
</mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karila</surname><given-names>L</given-names></name><name><surname>Weinstein</surname><given-names>A</given-names></name><name><surname>Aubin</surname><given-names>HJ</given-names></name><name><surname>Benyamina</surname><given-names>A</given-names></name><name><surname>Reynaud</surname><given-names>M</given-names></name><name><surname>Batki</surname><given-names>SL</given-names></name></person-group>
<article-title>Pharmacological approaches to methamphetamine dependence: a focused review</article-title>. <source>Br J Clin Pharmacol</source>
<year>2010</year>; <volume>69</volume>: <fpage>578</fpage>-<lpage>92</lpage>.
<pub-id pub-id-type="pmid">20565449</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>NK</given-names></name><name><surname>Rawson</surname><given-names>RA</given-names></name></person-group>
<article-title>A systematic review of cognitive and behavioural therapies for methamphetamine dependence</article-title>. <source>Drug Alcohol Rev</source>
<year>2008</year>; <volume>27</volume>: <fpage>309</fpage>-<lpage>17</lpage>.
<pub-id pub-id-type="pmid">18368613</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guyll</surname><given-names>M</given-names></name><name><surname>Spoth</surname><given-names>R</given-names></name><name><surname>Crowley</surname><given-names>DM</given-names></name></person-group>
<article-title>Economic analysis of methamphetamine prevention effects and employer costs</article-title>. <source>J Studies Alcohol Drugs</source>
<year>2011</year>; <volume>72</volume>: <fpage>577</fpage>.
</mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ettner</surname><given-names>SL</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Evans</surname><given-names>E</given-names></name><name><surname>Rose Ash</surname><given-names>D</given-names></name><name><surname>Hardy</surname><given-names>M</given-names></name><name><surname>Jourabchi</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Benefit-cost in the California Treatment Outcome Project: does substance abuse treatment &#x02018;pay for itself&#x02019;?</article-title>
<source>Health Serv Res</source>
<year>2006</year>; <volume>41</volume>: <fpage>192</fpage>-<lpage>213</lpage>.
<pub-id pub-id-type="pmid">16430607</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dobkin</surname><given-names>C</given-names></name><name><surname>Nicosia</surname><given-names>N</given-names></name></person-group>
<article-title>The war on drugs: methamphetamine, public health, and crime</article-title>. <source>Am Econ Rev</source>
<year>2009</year>; <volume>99</volume>: <fpage>324</fpage>.
<pub-id pub-id-type="pmid">20543969</pub-id></mixed-citation></ref></ref-list></back></article>